Test Session 1
Mar 17, 2023 10:00am ‐ Mar 31, 2023 10:00am
Identification: testses1
Learning Objectives:- Objective 1
- Objective 2
- Objective 3
- Objective 4
Speaker(s):
- Jacqueline E. Lombardi, Project Manager, BroadcastMed
- Annamarie Luccarelli
- Patricia McLafferty, CHCP, BroadcastMed
Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis
Jun 13, 2023 3:00pm ‐ Jun 13, 2023 4:00pm
Identification: web230613
Speaker(s):
- Charina Toste, DNP, RN, APRN-C, AOCNP
Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis
Jun 14, 2023 4:00pm ‐ Jun 14, 2023 5:00pm
Identification: web230614
Speaker(s):
- Lindsey Lyle, MS, PA-C
Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis
Jun 15, 2023 12:00pm ‐ Jun 15, 2023 1:00pm
Identification: web230615
Speaker(s):
- Christopher Nelson, MSN, MBA, CNP, Certified Nurse Practitioner, Avera Health
Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis
Jun 20, 2023 3:00pm ‐ Jun 20, 2023 4:00pm
Identification: web230620
Speaker(s):
- Krista Tucker, ANP-BC, AOCN, Tufts Medical Center
Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis
Jun 21, 2023 12:00pm ‐ Jun 21, 2023 1:00pm
Identification: web230621
Speaker(s):
- Heather Bowers, MSN, ACNP-BC, Prisma Cancer Institute